Compare ALLO & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | XRX |
|---|---|---|
| Founded | 2017 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 416.3M |
| IPO Year | 2018 | 2019 |
| Metric | ALLO | XRX |
|---|---|---|
| Price | $0.76 | $0.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | ★ $9.00 | $1.75 |
| AVG Volume (30 Days) | ★ 11.2M | 9.4M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 10.94% |
| EPS Growth | ★ 34.09 | 23.26 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $117,000,000.00 |
| Revenue This Year | N/A | $8.08 |
| Revenue Next Year | $72.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.74 | $0.88 |
| 52 Week High | $4.46 | $3.78 |
| Indicator | ALLO | XRX |
|---|---|---|
| Relative Strength Index (RSI) | 21.26 | 19.20 |
| Support Level | N/A | N/A |
| Resistance Level | $2.25 | $1.92 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 0.42 | 2.70 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.